Factores determinantes del riesgo isquémico del paciente tras un infarto agudo de miocardio

Abstract

The assessment of ischemic risk in patients presenting with a myocardial infarction is crucial for helping to select (from hospital admission onwards) the best management strategy and for deciding which antiplatelet treatment will produce the greatest improvement in prognosis. Risk assessments, which have improved in recent years, provide us with quantitative indicators of the patient’s short-and long-term prognosis. This article contains a review of the different approaches to ischemic risk assessment in patients admitted with an infarction, the most commonly used risk scores, the assessment of residual risk in patients with an infarction and the identification of patients with an elevated medium-and long-term risk. It also considers how angiographic characteristics and percutaneous revascularization influence prognosis in these patients.